ECS modulator (research)
Narcotic: generic clauseJWH-193
(4-méthylnaphtalén-1-yl)-[1-(2-morpholin-4-yléthyl)indol-3-yl]méthanone
Aliases.JWH-193 · 4-méthylnaphtoyl-JWH-200
A synthetic naphthoylindole, a highly affine CB1 agonist; classified as a narcotic in France by generic clause.
Updated on
Level of detail
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
Identifiers
- Formula
- C₂₆H₂₆N₂O₂
- Molar mass
- 398.50 g·mol⁻¹
- CAS
- 133438-58-1
- PubChem CID
- 10250276
- Origin
- A wholly synthetic compound. It has no natural occurrence, is found in no plant and is not a product of metabolism. Its production belongs to the laboratory, for pharmacological research purposes, and to clandestine manufacture intended for the synthetic cannabinoid market.
- InChIKey
- ICKWPPYMDARCKJ-UHFFFAOYSA-N
In plain terms
JWH-193 is a synthetic cannabinoid, with no botanical relation to hemp. It binds very strongly to the CB1 receptor, far more than THC. No human study exists, no dose is known, and it is classified as a narcotic in France.
Receptors and activity
- CB1Affinité rapportée de l'ordre de 6 nM (Huffman et Padgett 2005)Agonist
- CB2Affinité non déterminée pour ce composé précisAgonist
- Agonist
- Partial agonist
- Antagonist
- Modulator
- Inverse agonist
Hover over a row for the precise value (Ki, EC50…)
Subjective signature
Hover over an axis to read its definition.
- Calm20
- Clarity5
- Sleep30
- Appetite40
- High60
Editorial estimate, not clinical.
Pharmacology
JWH-193 belongs to the naphthoylindole family, those synthetic cannabinoids built on an indole core linked by a ketone to a naphthalene, whose leader JWH-018 opened the market in products sold under the misleading label of incense or smoking mixtures. It is distinguished by its morpholinoethyl chain borne by the indole nitrogen, inherited from JWH-200, and by a methyl at position 4 of the naphthalene. That last modification is the compound's reason for existing within the series: it multiplies by about seven the affinity for the CB1 receptor, which stands around 6 nanomolar, far above that of Δ9-THC. The structure-activity relationship work of Huffman and his team, covering dozens of analogues, served precisely to map the effect of naphthalene substituents and of N-alkyl chain length on CB1 affinity and on CB2 selectivity, and to identify along the way several highly selective CB2 agonists. What this entry cannot say must be stressed. No specific functional efficacy study, no pharmacokinetic, metabolic or human toxicology data are published for this compound. The risks documented for the whole class of synthetic CB1 agonists, most of which are full agonists where THC is only a partial agonist, cannot be quantified for it in particular, but they apply by construction: agitation, tachycardia, convulsions and acute psychiatric disturbances have been reported for this entire family.
Origin (research tool)
An entirely chemical route, described here by class only. The molecule combines three elements assembled by synthesis: an indole core, a ketone function linking position 3 of that indole to a methylated naphthalene, and a morpholinoethyl chain borne by the indole nitrogen. It does not exist in nature and proceeds from no enzymatic route.
Legal framework
France
A narcotic. The molecule is a derivative of 3-(1-naphthoyl)indole substituted on the nitrogen, and on that account falls under the generic clause targeting synthetic cannabinoids in Annex IV of the arrêté of 22 February 1990, which covers that family with its isomers, stereoisomers, esters, ethers and salts. Its possession, transfer and use are prohibited.
European Union
The compound is named neither in the schedules of the 1971 convention nor in a control decision proper to the Union. It is, however, captured by the generic clauses on naphthoylindoles adopted by several Member States, including France, and by analogous arrangements outside the Union. Synthetic cannabinoids are the subject of continuous monitoring by the European early warning system.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Structural classification
- Class
- ECS modulator (research)
- Origin
- A wholly synthetic compound. It has no natural occurrence, is found in no plant and is not a product of metabolism. Its production belongs to the laboratory, for pharmacological research purposes, and to clandestine manufacture intended for the synthetic cannabinoid market.
- Status
- Narcotic: generic clause
References
Structured data
- InChIKey
- ICKWPPYMDARCKJ-UHFFFAOYSA-N
- SMILES
- CC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCN5CCOCC5
- Formula
- C26H26N2O2
- Molar mass
- 398.50 g·mol⁻¹
- CAS
- 133438-58-1
- PubChem CID
- 10250276
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.